Stock’s Buzz: Americann Inc (ACAN), Earth Science Tech Inc (ETST), AeroGrow International, Inc. (AERO)
Americann Inc (OTCMKTS:ACAN) showing jumped of 2.93% and closed at $3.94, after gaining total volume of 0.00 shares. Its earnings per share (EPS) are -$0.13 and It has total market capitalization of $75.38 million and a total of 19.13 million outstanding shares.
AmeriCann, Inc. focuses on providing consulting, design, construction, and financing to marijuana operators in the United States. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in February 2014. AmeriCann, Inc. was founded in 2010 and is based in Denver, Colorado.
Earth Science Tech Inc (OTCMKTS:ETST) reported the surge of 0.62% and closed at $1.62, with the total traded volume of 0.00 shares. During last trade its minimum price was $1.61 and it gained its highest price of $1.68 and has a total of 40.91 million outstanding shares.
On March 27, 2017 Earth Science Tech, Inc. (ETST), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices, and its two subsidiaries – Earth Science Pharmaceutical Inc. and Cannabis Therapeutics inc. – are proud to announce the projected timeline for the delivery of its MSN-2 medical device; the negotiation of a strategic partnership with Connexions Commerciales Internationales ct, Inc.; and the beginning of negotiations with partners in Africa and Japan.
The MSN-2 medical devicewasannouncedin November 2016, (https://globenewswire.com/news-release/2016/11/21/891699/0/en/ETST-Announces-60-Patient-Clinical-Prelaunch-Study-for-its-MSN-2-Medical-Device-for-the-Diagnosis-of-Chlamydia-Gonorrhea-ETST-Elects-Dr-Michel-Aubé-as-New-CEO-CSO-and-Nickolas-Tabr.html). The above mentioned medical device can be used by women to extract a cell sample from herself, which then is shipped to a proprietary lab for analysis of sexually transmitted infections. Our device is proven to sample for chlamydia and is currently undergoing testing to certify the device for gonorrhea sampling.
AeroGrow International, Inc. (OTCMKTS:AERO) increased 0.35% closed at $2.83 and traded with total volume of 0.00 shares, while the average trading remained 26,333.00 shares. During last trade its minimum price was $2.78 and it gained the highest price of $2.95. Its market capitalization was $94.74 million.
AeroGrow International, Inc. (AERO) on February 14, 2017 announced results for the third quarter ended December 31, 2016.
For the quarter the Company recorded total net revenue of $13.2 million, up from $11.9 million the prior year. Adjusted EBITDA was $1.48 million, down from $1.65 million, primarily due to increased advertising spending to further build the brand. For the nine months ended December 31, sales rose + 21% to $17.6 million from $14.5 million in the previous year, and adjusted EBITDA stands at $697 thousand, + 470% vs. $122 thousand in the prior year.
“I’m very pleased to report on our 2016 holiday selling season — overall the best in our Company’s history,” said President and CEO J. Michael Wolfe. “Our focus this year was to continue the growth in our highly successful on-line channels and to establish in-store success with prominent national retailers. The results were exceptional as we experienced + 49% sell-thru growth at Amazon.com and + 101% at Amazon.ca. We also had good results with our other on-line retailers, including a very successful launch at Target.com. But I think the really big news for us was the success we had in-store as we experienced nearly 100% chain-wide sell-thru at Bed, Bath & Beyond and Sur La Table, with high-profile rollouts at both stores.
“We have worked hard to get our product line, our advertising, our point of purchase merchandising and our mix of stores optimized so that we could begin seeing good success in brick and mortar retail. This resulted in our spending more on media than we have previously, but drove excellent sell-thru and I truly think we’ve now ‘cracked the code’ on achieving in-store retail success. We believe we are poised to grow this channel significantly.